Lisinopril
Product Images NDC 53002-2123

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 53002-2123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)

Lisinopril (133b3fec 07f6 41f5 9c7c 50b66c4c0677 01)
Chemical structure of Lisinopril dihydrate showing its molecular framework with labeled atoms and bonds, including the phenyl group, amino acid side chains, and hydrated water molecules (2H2O).*
FDA Label Image

Label Image (Lbl530022123)

Label Image (Lbl530022123)
Packaging label for Lisinopril 10 mg tablets by RPK Pharmaceuticals, Inc., containing 30 tablets. The label includes directions to take one tablet daily or as directed, along with lot number, expiration date, and barcode. It specifies prescription use only and displays patient and prescriber information fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.